Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

01-04-2012 | Letter to the Editor

Further Commentary on Mitochondrial Dysfunction in Autism Spectrum Disorder: Assessment and Treatment Considerations

Auteurs: Stephen R. Dager, Neva M. Corrigan, Annette Estes, Dennis W. W. Shaw

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 4/2012

Abstract

The authors respond to a recent letter (Rossignol and Frye 2011) critical of their paper, “Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder” (Corrigan et al. 2011). Further considerations regarding the assessment of mitochondrial dysfunction in autism spectrum disorder, and related treatment considerations, are discussed.

vorige artikel Substantial Problems with Measuring Brain Mitochondrial Dysfunction in Autism Spectrum Disorder Using Magnetic Resonance Spectroscopy

volgende artikel Sarita Freedman: Developing College Skills in Students With Autism and Asperger’s Syndrome

Amundsen, L. B., Artru, A. A., Dager, S. R., Shaw, D. W. W., Friedman, S., Sparks, B., et al. (2005). Propofol sedation for longitudinal pediatric neuroimaging research. Journal of Neurosurg Anesthesiology, 17(4), 180–192.CrossRef

Bianchi, M. C., Sgandurra, G., Tosetti, M., Battini, R., & Cioni, G. (2007). Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosciene Reports, 27(1–3), 69–85.CrossRef

Coleman, M., & Blass, J. P. (1985). Autism and lactic acidosis. Journal of Autism and Developmental Disorders, 15(1), 1–8.PubMedCrossRef

Correia, C., Coutinho, A. M., Diogo, L., Grazina, M., Marques, C., Miguel, T., et al. (2006). Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. Journal of Autism and Developmental Disorders, 36(8), 1137–1140.PubMedCrossRef

Corrigan, N. M., Richards, T. L., Friedman, S. D., Petropoulos, H., & Dager, S. R. (2010). Improving 1H MRSI measurement of cerebral lactate for clinical applications. Psychiatry Research Neuroimaging, 182(1), 40–47.CrossRef

Corrigan, N. M., Shaw, D. W. W., Richards, T. L., Estes, A. M., Friedman, S. D., Petropoulos, H., et al. (2011). Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. Journal of Autism and Developmental Disorders. doi:10.1007/s10803-011-1216-y.

Dager, S. R. (2010). The vexing role of baseline: Implications for neuroimaging studies of panic disorder. International Journal of Psychophysiology, 78(1), 20–26.PubMedCrossRef

Dager, S. R., & Steen, R. G. (1992). Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. Neuropsychopharmacology, 6(4), 249–266.PubMed

Dager, S. R., Friedman, S. D., Heide, A., Layton, M. E., Richards, T., Artru, A., et al. (1999). Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Archieves of General Psychiatry, 56(1), 70–77.CrossRef

Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., et al. (2004). Brain metabolic alterations in medication-free patients with bipolar disorder. Archieves of General Psychiatry, 61(5), 450–458.CrossRef

Dager, S. R., Corrigan, N. M., Richards, T. L., & Posse, S. (2008). Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Topics in Magnetic Resonance Imaging, 19(2), 81–96.PubMedCrossRef

Dager, S., Corrigan, N., Richards, T., & Shaw, D. (2011). Brain chemistry: Magnetic resonance spectroscopy. In D. Amaral, G. Dawson, & D. Geshwind (Eds.), Autism Spectrum Disorder. Oxford: Oxford University Press.

Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., et al. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The early start denver model. Pediatrics, 125(1), e17–e23.PubMedCrossRef

Friedman, S. D., Dager, S. R., Richards, T. L., Petropoulos, H., & Posse, S. (2000). Modeling brain compartmental lactate response to metabolic challenge: A feasibility study. Psychiatry Research, 98(1), 55–66.PubMedCrossRef

Friedman, S. D., Shaw, D. W., Artru, A. A., Richards, T. L., Gardner, J., Dawson, G., et al. (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology, 60(1), 100–107.PubMed

Friedman, S. D., Shaw, D. W. W., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63(7), 786–794.PubMedCrossRef

Granpeesheh, D., Tarbox, J., Dixon, D., Wilke, A. E., Allen, S., & Bradstreet, J. J. (2010). Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders, 4, 265–268.

Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., et al. (2008). The in-depth evaluation of suspected mitochondrial disease. Molecular Genetics and Metabolism, 94(1), 16–37.PubMedCrossRef

Jepson, B., Granpeesheh, D., Tarbox, J., Olive, M. L., Stott, C., Braud, S., et al. (2011). Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 41(5), 575–588.PubMedCrossRef

Lyoo, I. K., Dager, S. R., Kim, J. E., Yoon, S. J., Friedman, S. D., Dunner, D. L., et al. (2010). Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology, 35(8), 1743–1750.PubMed

Morgan, P. (2007). When propofol is problematic. Paper presented at the12th annual joint winter meeting of the society of pediatric anesthesia and American academy of pediatrics., Phoenix, Arizona.

Oliveira, G., Diogo, L., Grazina, M., Garcia, P., Ataíde, A., Marques, C., et al. (2005). Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Developmental Medicine and Child Neurology, 47(3), 185–189.PubMedCrossRef

Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., Haas, R., et al. (2009). A modern approach to the treatment of mitochondrial disease. Current Treatment Options in Neurology, 11(6), 414–430.PubMedCrossRef

Posse, S., Dager, S. R., Richards, T. L., Yuan, C., Ogg, R., Artru, A. A., et al. (1997). In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI). Magnetic Resonance in Medicine, 37(6), 858–865.PubMedCrossRef

Ramocki, M. B., & Zoghbi, H. Y. (2008). Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature, 455(7215), 912–918.PubMedCrossRef

Rossignol, D. A., & Bradstreet, J. J. (2008). Evidence of mitochondrial dysfunction in autism and implications for treatment. American Journal of Biochemistry and Biotechnology, 4(2), 208–217.CrossRef

Rossignol, D. A., & Frye, R. E. (2011). Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy. Journal of Autism and Developmental Disorders. doi:10.1007/s10803-011-1276-z.

Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics, 9, 21.PubMedCrossRef

Saneto, R. P., Friedman, S. D., & Shaw, D. W. W. (2008). Neuroimaging of mitochondrial disease. Mitochondrion, 8(5–6), 396–413.PubMedCrossRef

Titel: Further Commentary on Mitochondrial Dysfunction in Autism Spectrum Disorder: Assessment and Treatment Considerations
Auteurs: Stephen R. Dager
Neva M. Corrigan
Annette Estes
Dennis W. W. Shaw
Publicatiedatum: 01-04-2012
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 4/2012
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-011-1352-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2012

Changes in the Administrative Prevalence of Autism Spectrum Disorders: Contribution of Special Education and Health from 2002–2008

Editorial: 2011 in Review

Long-term Cognitive and Behavioral Therapies, Combined with Augmentative Communication, are Related to Uncinate Fasciculus Integrity in Autism

Food Variety as a Predictor of Nutritional Status Among Children with Autism

Brief Report: Faces Cause Less Distraction in Autism

IQ Predicts Biological Motion Perception in Autism Spectrum Disorders